Commercial
Advanced Search
MPDocType
  
Title
  
MPPolicyNumber
  
MPNotificationIssuedDate
  
MPEffectiveDate
  
MPReissuedDate
  
MPArchiveNotifEffDate
  
MPSALogCreatedOn
  
MPPolicyChangeTypeslt
  
MPRevisionDate
  
MPSiteActivityRemovedDate
  
NotificationsPegloticase (Krystexxa®)08.01.02h2/24/2023 10:00 AM3/27/20232/24/2023Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
NotificationsVentricular Assist Devices (VADs)11.02.16u2/28/2023 11:00 AM5/29/20232/28/2023Medical Necessity Criteria;General Description, Guidelines, or Informational Update
New Policiesolipudase alfa-rpcp (Xenpozyme™)08.01.962/13/20232/13/2023This is a New Policy.
Updated PoliciesCochlear Implantation11.01.02q11/7/2022 10:00 AM11/7/202211/7/20222/6/2023Medical Coding
Updated PoliciesNeuropsychological Testing for Neurologically Based Conditions07.03.08m11/7/2022 10:00 AM2/6/20232/6/2023Coverage and/or Reimbursement Position;Medical Necessity Criteria;General Description, Guidelines, or Informational Update
Updated PoliciesBlinatumomab (Blincyto®)08.01.21f2/27/20232/27/2023Medical Necessity Criteria;General Description, Guidelines, or Informational Update
Updated PoliciesLower Limb Prostheses05.00.59l2/27/20232/27/2023Coverage and/or Reimbursement Position;General Description, Guidelines, or Informational Update
Updated PoliciesEptinezumab-jjmr (VYEPTI™)08.00.45c2/27/20232/27/2023Medical Necessity Criteria
Reissue PoliciesComputer-assisted Musculoskeletal Surgical Navigational Orthopedic Procedure11.14.17e1/1/20212/8/20232/8/2023
Reissue PoliciesLow-Level laser Therapy07.00.14g9/30/20192/8/20232/8/2023
Reissue Policiesevinacumab-dgnb (Evkeeza™) 08.01.76b10/1/20212/8/20232/8/2023
Reissue Policiescrizanlizumab-tmca (Adakveo®)08.00.0411/30/20202/8/20232/8/2023
Reissue PoliciesComposite Tissue Allotransplantation of the Hand(s) and Face11.14.305/19/20172/22/20232/22/2023
Reissue PoliciesHair Transplants and Cranial Prostheses (Wigs)11.08.01g9/9/20192/22/20232/22/2023
Reissue PoliciesBalloon Catheter Dilation of Sinus Ostia for Treatment of Chronic Rhinosinusitis11.16.06j1/1/20202/22/20232/22/2023
Reissue PoliciesRoutine Foot Care for Certain Medical Conditions07.07.01q10/1/20212/22/20232/22/2023
Reissue PoliciesNerve Fiber Density Testing06.02.38d1/1/20192/22/20232/22/2023
Reissue PoliciesNatalizumab (Tysabri®)08.00.64g10/21/20192/22/20232/22/2023
Reissue PoliciesExtracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions11.14.13h1/1/20222/22/20232/22/2023
Reissue PoliciesComputer-Aided Detection (CAD) System for Use with Chest Radiographs09.00.42c3/11/20152/22/20232/22/2023
Reissue PoliciesApplication and Removal of Tattoos11.08.05g7/20/20122/22/20232/22/2023
Reissue PoliciesManipulation Under Anesthesia11.14.24b4/30/20182/22/20232/23/2023
Reissue PoliciesNon-Surgical Spinal Decompression Therapy07.08.01f3/28/20162/22/20232/23/2023
Reissue PoliciesPercutaneous Intradiscal Annuloplasty (IDET/PIRFT)11.14.14e7/1/20132/22/20232/23/2023
Reissue PoliciesPercutaneous Discectomy11.15.15g12/1/20172/22/20232/23/2023
Coding UpdateBilling for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus00.10.39p1/1/20232/10/2023
Coding UpdateCare Management and Care Planning Services00.01.59m1/1/20232/10/2023
Coding UpdateConsultation Services00.01.69b1/1/20232/10/2023
Coding UpdateDirect Access to Obstetrics/Gynecology (OB/GYN) Services00.09.01j1/1/20232/13/2023
Coding UpdatePharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy (Independence Administrators)06.02.18m1/1/20232/16/2023
Coding UpdateGenetic Testing (Independence Administrators)06.02.35ai1/1/20232/16/2023
Connect with Us

2023 Independence Blue Cross

Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.